Samsung Bioepis Reaches Settlement Agreement for PYZCHIVA® (ustekinumab) in Europe
强生(US:JNJ) Businesswire·2025-11-06 15:00INCHEON, Korea--(BUSINESS WIRE)-- #biosimilars--Samsung Bioepis has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of PYZCHIVA®, in Europe. ...